Welcome to LookChem.com Sign In|Join Free

CAS

  • or

213552-25-1

Post Buying Request

213552-25-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

213552-25-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 213552-25-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,3,5,5 and 2 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 213552-25:
(8*2)+(7*1)+(6*3)+(5*5)+(4*5)+(3*2)+(2*2)+(1*5)=101
101 % 10 = 1
So 213552-25-1 is a valid CAS Registry Number.

213552-25-1Downstream Products

213552-25-1Relevant articles and documents

Comparative inhibitory activity of 3′- and 5′-functionalized nucleosides on ribonuclease A

Debnath, Joy,Dasgupta, Swagata,Pathak, Tanmaya

, p. 8257 - 8263 (2010)

Modified nucleosides, molecules, functionalized with various polar groups at different positions have been synthesized to rationalize the impact of structural modification on their inhibitory activity. Agarose gel and precipitation assays indicate their improved inhibitory activity on ribonuclease A (RNase A). Kinetic experiments clearly categorize them as competitive inhibitors of RNase A with improved inhibition constant (Ki) values (37 ± 9, 67 ± 6, and 193±7 μM for compounds 10, 3, and 7, respectively). The preferential hydrogen bonding network formation between His-12 and His-119 of RNase A with the polar carboxylic and amino groups of these compounds has been evidenced from the docking studies. The relationship between structural modifications and inhibitory activity of these compounds is further justified in terms of energetics using PEARLS.

Synthesis and Biological Evaluation of 5-Fluoro-2'-deoxyuridine Phosphoramidate Analogs

Fries, Kristin M.,Joswig, Carolyn,Borch, Richard F.

, p. 2672 - 2680 (2007/10/03)

A series of alkylating phosphoroamidate analogs of 5-fluoro-2'-deoxyuridine has been prepared and their growth inhibitory activity evaluated against murine L1210 leukemia and B16 melanoma cells in vitro.These compounds were designed to undergo intracellular release of the phosphoramidate anions, which it was hoped would function as irreversible inhibitors of thymidylate synthase.The expectation was that binding of the nucleoside moiety would be followed by alkylation of the enzyme via the phosphoramidate.The chloride, bromide, iodide, and tosylate analogs were highlypotent inhibitors of L1210 cell proliferation, with increased inhibition observed at both higher drug concentrations and longer exposure times.Addition of thymidine completely reversed the inhibition for all compounds, suggesting that these compounds are acting via inhibition of thymidylate synthase.Although the nonalkylating morpholine analog 1f was ca. 50-fold less potent than the methyl(chloroethyl)amino compound, the piperidine analog 1g was only 2-fold less potent, confirming that nitrogen basicity may be as important as the presence of an alkylating group.Addition of thymidine reversed the growth inhibition of the morpholine and piperidine analogs, suggesting that these compounds may also undergo intracellular conversion to 5-fluoro-2'-deoxyuridine 5'-monophosphate.The thymidine and deoxyuridine derivatives 2 and 3 showed minimal growth inhibition in the L1210 assay.The alkylating analogs showed modest cytotoxicity against B16 melanoma cells, and the potency of the analogs was more dependent upon the alkylating moiety than on the 5-substituent.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 213552-25-1